Ciocca Automotive York Region’s Post

The use of cannabis in chronic pain has not been proven. Raw cannabis is not medicine, but components of the plant may have medicinal value, just like many chemotherapeutic agents which have met the muster of scientific rigor. Looking forward to this

In this episode of How This Is Building Me, Drs Camidge and Garon discuss the importance of continuing to ask a variety of research questions throughout one’s career; the value of negative study results; and the ins and outs of running the lung cancer program and conducting phase 3 clinical trials at UCLA Health. #OncLiveOnAir https://lnkd.in/eJPsfT5Y

Today is #WorldCancerResearchDay, and we want to take a moment to enthusiastically endorse the goals outlined in the World Declaration for Research on Cancer. Please read the Declaration here: https://lnkd.in/ddff5-gS

📢 Dive into the MDS Clinical Roadmap with MD Education! Join us monthly for in-depth MDS insights. 🗓️ From Feb 2023-2024 🔬 Featuring Dr. Rami Komrokji, MD from Moffitt Cancer Center & Guests 🎥 20-min presentations + 10-min Q&A. Missed our earlier sessions? No worries! Register to view past and future content. 🔄https://lnkd.in/egAdmGdf #MDSClinicalRoadmap #HCPs #MDSeducation #MonthlyInsights

Our progress in 2022/23 brings us closer to ensuring new discoveries and insights from research ultimately help people with cancer. Find out more about our achievements so far – and the road ahead - in our Annual Review: https://bit.ly/3sZ2ANO

"Between 1989 and 1993, inclusion of women in clinical research was NIH policy, but it was not law. In 1993, Congress wrote the NIH inclusion policy into Federal law through a section in the NIH Revitalization Act of 1993 (Public Law 103-43) titled Women and Minorities as Subjects in Clinical Research. 10  The law includes various requirements for NIH-funded research, including the following: *NIH ensures that women and minorities are included in all clinical research. *In trials including women and minorities, the trial should be designed and carried out so that it is possible to analyze whether the variables being studied affect women and minorities differently than other participants. *Cost is not an acceptable reason for excluding women and minorities. *NIH initiates programs and support for outreach efforts to recruit and retain women and minorities and their subpopulations as volunteers in clinical studies." - NIH I was already 20 when women were just starting to be considered for clinical trials...! We (Stack ) are getting there; training and upskilling the future of the clinical research workforce. https://bit.ly/4dPBY56 #womenshealth #clinicalresearch #diversity #workforcedevelopment

RNIB and Macmillan Cancer Support come together to ‘see cancer differently’, highlighting the importance of accessible information and support #seedifferently

Here's the latest from the Community & Cancer Science Network (CCSN).

DCEG experts are participating in this important meeting.

Today is World Cancer Day, learn more about the background of this day and about SIP's work in the field of cancer-related pain here: https://brnw.ch/21wGF6g